Literature DB >> 11290423

Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family.

R Vidal1, M Calero, T Révész, G Plant, J Ghiso, B Frangione.   

Abstract

The BRI3 gene is a member of the BRI gene family, made up of at least three different genes (BRI1-3). Previous studies established the cDNA sequence and structure of the human and mouse BRI1 and BRI2 genes and we recently reported that mutations in the BRI2 isoform, located on chromosome 13, are associated with dementia in humans. In the present work, we determine the complete cDNA sequence and genomic organization of the human BRI3 gene. BRI3 codes for a polypeptide of 267 amino acids, with a Mr of 30 KDa and a pI of 8.47. The amino acid sequence is 43.7% identical to the sequence of the human BRI2, and 38.3% identical to that of human BRI1, with the highest percentage of amino acid identity being concentrated on the C-terminal half of the molecules. In Northern blots, BRI3 cDNA hybridizes only one message of approximately 2.1 kilobases, which is predominantly present in the human brain. The BRI3 gene is localized on chromosome 2 and consists of six exons spanning more than 20 kb. Homology search of EST data banks retrieved a Caenorhabditis briggsae homolog of BRI, indicating that the BRI gene belongs to a strongly conserved gene family. These studies, aimed at characterizing the members of the BRI gene family, may provide valuable clues to the understanding of their normal function and how mutations in BRI2 can cause neurodegeneration and dementia similar to Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290423     DOI: 10.1016/s0378-1119(01)00374-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  BRI2 (ITM2b) inhibits Abeta deposition in vivo.

Authors:  Jungsu Kim; Victor M Miller; Yona Levites; Karen Jansen West; Craig W Zwizinski; Brenda D Moore; Fredrick J Troendle; Maralyssa Bann; Christophe Verbeeck; Robert W Price; Lisa Smithson; Leilani Sonoda; Kayleigh Wagg; Vijayaraghavan Rangachari; Fanggeng Zou; Steven G Younkin; Neill Graff-Radford; Dennis Dickson; Terrone Rosenberry; Todd E Golde
Journal:  J Neurosci       Date:  2008-06-04       Impact factor: 6.167

2.  Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis.

Authors:  Robert Tamayev; Luca Giliberto; Wei Li; Cristina d'Abramo; Ottavio Arancio; Ruben Vidal; Luciano D'Adamio
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

3.  Amyloid and intracellular accumulation of BRI2.

Authors:  Holly J Garringer; Neeraja Sammeta; Adrian Oblak; Bernardino Ghetti; Ruben Vidal
Journal:  Neurobiol Aging       Date:  2016-12-29       Impact factor: 4.673

4.  Clptm1 Limits Forward Trafficking of GABAA Receptors to Scale Inhibitory Synaptic Strength.

Authors:  Yuan Ge; Yunhee Kang; Robert M Cassidy; Kyung-Mee Moon; Renate Lewis; Rachel O L Wong; Leonard J Foster; Ann Marie Craig
Journal:  Neuron       Date:  2018-01-25       Impact factor: 17.173

5.  MicroRNA-323 regulates ischemia/reperfusion injury-induced neuronal cell death by targeting BRI3.

Authors:  Liu Yang; Yin Xiong; Xian-Feng Hu; Yan-Hua Du
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2.

Authors:  Shuji Matsuda; Yukiko Matsuda; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

7.  Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles.

Authors:  Shuji Matsuda; Yukiko Matsuda; Erik L Snapp; Luciano D'Adamio
Journal:  Neurobiol Aging       Date:  2009-09-12       Impact factor: 4.673

8.  Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice.

Authors:  Holly J Garringer; Jill Murrell; Neeraja Sammeta; Anita Gnezda; Bernardino Ghetti; Ruben Vidal
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Novel subtractive transcription-based amplification of mRNA (STAR) method and its application in search of rare and differentially expressed genes in AD brains.

Authors:  Qing Yan Liu; Roy R Sooknanan; Lawrence T Malek; Maria Ribecco-Lutkiewicz; Joy X Lei; Hui Shen; Boleslaw Lach; P Roy Walker; Joel Martin; Marianna Sikorska
Journal:  BMC Genomics       Date:  2006-11-07       Impact factor: 3.969

10.  Generation and initial characterization of FDD knock in mice.

Authors:  Luca Giliberto; Shuji Matsuda; Ruben Vidal; Luciano D'Adamio
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.